Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by gericon Jan 18, 2014 7:46pm

207 Views

Post# 22108139

RE:RE:RE:RE:RE:Therapies for People with Low HDL: None

Kayaker, I applaud your insight. You are absolutely correct. It's amazing how many people tell me they eat healthy but on further examination it's quite the opposite. Most people don't have a clue. You wouldn't believe the gems I hear from patients.......

- " I use sea salt, it doesn't have any sodium in it"
- " If I cook the beef well done then it's not red meat right?"
- " I can't lose weight 'cause I have a glandular condition."

I would say less than 5% have a metabolism disorder. The rest is gluttony.

Bullboard Posts

Critical raw materials pioneer drives Europe’s clean energy transition